About Us
PharmaBridge International is a Government of India-registered healthcare company, established in June 2024 and headquartered in Ghaziabad, Uttar Pradesh. As a subsidiary of Mahimedicos, it is committed to delivering high-quality, affordable, and FDA-approved pharmaceutical solutions to patients worldwide.
With operations extending to the USA, UK, Australia, and beyond, PharmaBridge International specializes in providing a diverse range of therapeutic products, ensuring strict adherence to international regulatory standards. The company leverages cutting-edge technology and rigorous research to address various medical needs, from chronic conditions to innovative treatments.
PharmaBridge International collaborates with world-class healthcare institutions, research organizations, and supply chain partners to maintain an uninterrupted flow of life-saving medications. Its robust infrastructure and patient-first approach position the company as a leader in the pharmaceutical industry.
The company's mission is to bridge healthcare gaps by making modern treatments accessible to everyone. Through relentless dedication to quality, transparency, and patient safety, PharmaBridge International is reshaping the global healthcare landscape, empowering individuals and communities to lead healthier lives.